Amphastar Pharmaceuticals AMPH Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's operating cash flow?
- Amphastar Pharmaceuticals (AMPH) reported operating cash flow of $47.84M in Q1 2026.
- How has Amphastar Pharmaceuticals's operating cash flow changed year-over-year?
- Amphastar Pharmaceuticals's operating cash flow increased by 36.4% year-over-year, from $35.08M to $47.84M.
- What is the long-term trend for Amphastar Pharmaceuticals's operating cash flow?
- Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's operating cash flow has grown at a 12.3% compound annual growth rate (CAGR), from $97.99M to $156.12M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.